Sema4 CFO Isaac Ro to depart Aug. 9, 2022; Richard Miao named interim CFO

GeneDx Holdings Corp.

CFO Isaac Ro to leave Aug. 9, 2022; entitled to 9 months salary continuation and 12 months COBRA.
Richard Miao, SVP of FP&A and Treasurer, promoted to Deputy CFO and Interim CFO effective June 13.
Ro enters 6-month consulting agreement for advisory services with continued equity vesting.
Company reaffirms financial guidance provided May 12, 2022; search for permanent CFO engaged via Russell Reynolds.
Amendment extends Dr. Eric Schadt's 'Good Reason' notice period through April 28, 2023.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Isaac Ro

Chief Financial Officer

WGS · GeneDx Holdings Corp.

Effective: 2022-08-09
Successor: Richard Miao
Filed: June 14, 2022, 7:59 PM ET

its Chief Financial Officer, Isaac Ro, will leave the Company to pursue other career opportunities.

Appointed (interim)

Richard Miao

Interim Chief Financial Officer

WGS · GeneDx Holdings Corp.

Effective: 2022-06-13
Filed: June 14, 2022, 7:59 PM ET

Richard Miao, the Company’s current Senior Vice President of Financial Planning & Analysis and Treasurer, was promoted to Deputy Chief Financial Officer and appointed to serve as the Interim Chief Financial Officer, effective June 13, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Isaac Ro resigned as Chief Financial Officer at GeneDx Holdings Corp..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

its Chief Financial Officer, Isaac Ro, will leave the Company to pursue other career opportunities.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Miao was appointed as Interim Chief Financial Officer at GeneDx Holdings Corp..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

Richard Miao, the Company’s current Senior Vice President of Financial Planning & Analysis and Treasurer, was promoted to Deputy Chief Financial Officer and appointed to serve as the Interim Chief Financial Officer, effective June 13, 2022.

View on SEC.gov

GeneDx Holdings Corp. filing history →

Source: SEC EDGAR

accession 0001818331-22-000053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.